We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
801
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.61M | 0.01% |
603,725
+3,725
| +0.6% | +$22K |
|
|
BTAI
802
DELISTED
BioXcel Therapeutics
BTAI
| $3.6M | 0.01% |
4,238
-1,260
| -23% | -$822K |
|
|
CADE
803
DELISTED
Cadence Bank
CADE
| $3.59M | 0.01% |
158,050
-257,422
| -62% | -$5.46M |
|
804
Reliance Steel & Aluminium
RS
$20.1B
| $3.57M | 0.01% |
37,650
+5,599
| +17% | +$511K |
|
805
Funko
FNKO
$295M
| $3.56M | 0.01% |
+614,404
| New | +$2.98M |
|
|
FBC
806
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.56M | 0.01% |
120,804
+15,631
| +15% | +$400K |
|
807
Albertsons Companies
ACI
$6.1B
| $3.55M | 0.01% |
+225,000
| New | +$3.51M |
|
808
OGE Energy
OGE
$9.5B
| $3.54M | 0.01% |
116,739
+63,865
| +121% | +$1.97M |
|
|
SCWX
809
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $3.53M | 0.01% |
308,742
+165,563
| +116% | +$1.97M |
|
810
Paycom
PAYC
$10.3B
| $3.52M | 0.01% |
11,374
+9,977
| +714% | +$2.66M |
|
|
TSE
811
DELISTED
Trinseo
TSE
| $3.52M | 0.01% |
158,767
-359,938
| -69% | -$7.37M |
|
812
AppFolio
APPF
$7.83B
| $3.49M | 0.01% |
+21,456
| New | +$2.81M |
|
813
Lexicon Pharmaceuticals
LXRX
$899M
| $3.41M | 0.01% |
1,709,776
+992,069
| +138% | +$1.94M |
|
|
WTRU
814
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
| $3.39M | 0.01% |
59,953
-27,605
| -32% | -$1.56M |
|
|
NUVA
815
DELISTED
NuVasive, Inc.
NUVA
| $3.37M | 0.01% |
60,581
-208,976
| -78% | -$12.1M |
|
816
SS&C Technologies
SSNC
$18.9B
| $3.36M | 0.01% |
59,528
-89,390
| -60% | -$4.87M |
|
817
Globus Medical
GMED
$10.1B
| $3.35M | 0.01% |
70,227
-113,787
| -62% | -$5.49M |
|
818
Nasdaq
NDAQ
$49.6B
| $3.35M | 0.01% |
84,120
+65,031
| +341% | +$2.42M |
|
819
Deckers Outdoor
DECK
$10.6B
| $3.34M | 0.01% |
102,114
-50,256
| -33% | -$1.38M |
|
|
CCRD
820
DELISTED
CoreCard
CCRD
| $3.34M | 0.01% |
98,048
+56,568
| +136% | +$1.89M |
|
821
iShares Russell 2000 Value ETF
IWN
$14.1B
| $3.34M | 0.01% |
34,255
| – | – |
|
|
VG
822
DELISTED
Vonage Holdings Corporation
VG
| $3.33M | 0.01% |
330,941
-104,223
| -24% | -$935K |
|
823
Kennametal
KMT
$2.27B
| $3.32M | 0.01% |
115,651
-33,328
| -22% | -$849K |
|
824
Pathward Financial
CASH
$1.63B
| $3.31M | 0.01% |
182,029
+181,513
| +35,177% | +$3.18M |
|
825
Wells Fargo
WFC
$263B
| $3.3M | 0.01% |
129,079
-16,578
| -11% | -$454K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.